Outcomes and complications after transrectal ultrasound-guided prostate biopsy: A single-center study involving 425 consecutive patients

摘要: Objective: The use of 10–12-core systemic transrectal ultrasound (TRUS)-guided prostate biopsy protocols with extended-sampling has been an optimizing strategy for diagnosis cancer. In this study, we aim to examine the cancer detection rate (CDR) and complications following at our institution. Materials Methods: We retrospectively reviewed medical data patients who underwent TRUS-guided between 2007 2013 pathological outcomes, major complications, morbidities were recorded assessed clinically. Results: During study period, 425 enrolled. mean age participants was 67.9 years. Overall, 75 (17.6%) diagnosed Cancer detected in 0% (0/10), 7.0% (15/215), 16.5% (20/121), 50.6% (40/79) subgroups patient prostate-specific antigen (PSA) 20 ng/ml, respectively. optimal cutoff values PSA density 0.19, 0.29, 0.78 4–10 10–20 >20 ng/ml. total, 11 had afebrile urinary tract infections (UTI), 9 febrile UTI, another 2 septic shock after biopsy. overall incidence infectious 5.17% (22/425). Other infrequent, consisting only retention three patients, hematospermia two acute hemorrhagic cerebellar infarction 1 patient. Conclusion: Our demonstrated CDR, incidence, type Further prospective studies are required determine methods reducing from